|
Long-term immune-related adverse events under PD-1 inhibitors: a multicenter prospective cohort study (MELBASE). |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
|
|
|
Stock and Other Ownership Interests - Sanofi (I) |
Consulting or Advisory Role - Bristol-Myers Squibb |
Research Funding - Bristol-Myers Squibb (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis |
Speakers' Bureau - Bristol-Myers Squibb |
Research Funding - Bristol-Myers Squibb; MSD; Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
|
|
Honoraria - Bristol-Myers Squibb; MSD |
Consulting or Advisory Role - Bristol-Myers Squibb; Pierre Fabre |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pierre Fabre |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre |
Research Funding - Leo Pharma; Novartis |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Genevrier; Kiowa Kirin; Leo Pharma; MSD; Novartis; Pierre Fabre; Recordati |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre; Recordati |
|
|
Speakers' Bureau - Bristol-Myers Squibb; Janssen-Cilag |
Travel, Accommodations, Expenses - BMS Brazil; MSD Oncology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Merck; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Bristol-Myers Squibb; Pierre Fabre; Roche; Sanofi |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre; Roche |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Incyte; MSD; Novartis; Pfizer; Pierre Fabre; Roche |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche; Sanofi |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche |
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD |
Other Relationship - Avantis Medical Systems |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis |